Biocytogen Signs RenMab(TM)/RenLite(TM) Licensing Agreement wi...
- Written by LATEST ASIANET NEWS RELEASES
- Published in Asia Net
BEIJING, April 8, 2022 /PRNewswire-AsiaNet/ -- Biocytogen Pharmaceuticals (Beijing) Co., Ltd. announced that they have reached an agreement with BeiGene (Beijing) Co., Ltd. ("BeiGene") (NASDAQ code: BGNE; Hong Kong Stock Exchange code: 06160; Shanghai Stock Exchange code: 688235) on March 10, ...
Authors: LATEST ASIANET NEWS RELEASES